Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Effect of Preoperative Biliary Drainage on Postoperative Complications in Resectable Patients With Hilar Cholangiocarcinoma(Klatskin Tumor)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Lijian Liang
- Phone Number: 8096 86-20-87755766
- Email: lianglj@medmail.com.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- Recruiting
- Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University
-
Contact:
- Dong Chen, MD
- Phone Number: 8096 86-20-87755766
- Email: gzbobsums2004@hotmail.com
-
Principal Investigator:
- Lijian Liang
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients newly diagnosed
- Resectable patients after imaging assessment and evaluation of general condition of the patient
- TB>85μmol/L
- WBC account more than 1.5×109/L, PLT account more than 100×109/L and HB account more than 100g/L
- No serious disease in heart, lung and kidney
- Written informed consent
Exclusion Criteria:
- Unresectable patients.
- Patients have received biliary drainage procedure such as PTBD before admission
- Complicated with chronic hepatitis
- Myocardia infarction record within six months
- Women in pregnancy
- Serious disease in heart, lung or kidney
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Preoperative biliary drainage
|
Percutaneous transhepatic biliary drainage(PTBD) is performed under the guidance of ultrasound.
The duration may be around four weeks to make the total bilirubin of patients lower than 85μmol/L.
|
|
No Intervention: Controlled group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of postoperative complication
Time Frame: 30 days after operation
|
30 days after operation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postoperative mortality
Time Frame: 30 days after operation
|
30 days after operation
|
|
Overall survival, OS
Time Frame: May, 2013
|
May, 2013
|
|
Disease free survival, DFS
Time Frame: May, 2013
|
May, 2013
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Lijian Liang, Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University
- Principal Investigator: Xiaoyu Yin, MD, Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University
Publications and helpful links
General Publications
- Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9. doi: 10.1097/00000658-200110000-00010.
- Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayakawa N. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7(2):155-62. doi: 10.1007/s005340050170.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SUMS-5010
- cholangiocarcinoma
- Surgery
- DRAINAGE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.